The Patent Finder

Intellia Therapeutics, Inc.

24 patents currently held · Updated Nov 21, 2026
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
0
Ending by 2030
Dec 2037
Next term end

When these terms end

Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 1 fee due Dec 13, 2026
    The maintenance fee for Stabilized Nucleic Acids Encoding Messenger Ribonucleic Acid (mRNA) (US 11,673,911) comes due Dec 13, 2026. Unpaid by Jun 14, 2027, it lapses early.
  • 1 fee due Jan 11, 2027
    The maintenance fee for Polynucleotides, Compositions, and Methods for Genome Editing (US 11,697,806) comes due Jan 11, 2027. Unpaid by Jul 12, 2027, it lapses early.
  • 1 fee due Apr 24, 2027
    The maintenance fee for Compositions and Methods for TTR Gene Editing and Treating ATTR Amyloidosis (US 11,795,460) comes due Apr 24, 2027. Unpaid by Oct 25, 2027, it lapses early.
  • 1 fee due Jun 26, 2027
    The maintenance fee for Compositions and Methods for Immunooncology (US 11,851,659) comes due Jun 26, 2027. Unpaid by Dec 27, 2027, it lapses early.
  • 1 fee due Oct 23, 2027
    The maintenance fee for Compositions and Methods for TTR Gene Editing and Treating ATTR Amyloidosis (US 11,965,165) comes due Oct 23, 2027. Unpaid by Apr 24, 2028, it lapses early.

Which patents, and when each one lapses · Pro

Recent changes

  • 3 of the patents on this record were granted since Aug 23, 2026

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 12,173,284Modified Guide RNAs
In force
 · Medium confidence
In forceMedium confidence
US 12,735,698Modified Guide RNAs
In force
 · Low confidence
In forceLow confidence
US 12,460,205Compositions and Methods for Treating Alpha-1 Antitrypsin Deficiency
In force
 · Medium confidence
In forceMedium confidence
US 11,466,271Compositions and Methods for the Treatment of Hemoglobinopathies
In force
 · High confidence
In forceHigh confidence
US 11,795,460Compositions and Methods for TTR Gene Editing and Treating ATTR Amyloidosis
In force
 · Medium confidence
In forceMedium confidence
US 11,851,659Compositions and Methods for Immunooncology
In force
 · High confidence
In forceHigh confidence
US 12,391,722Stabilized Nucleic Acids Encoding Messenger Ribonucleic Acid (mRNA)
In force
 · Low confidence
In forceLow confidence
US 11,965,165Compositions and Methods for TTR Gene Editing and Treating ATTR Amyloidosis
In force
 · Medium confidence
In forceMedium confidence
US 11,479,767Modified Guide RNAs
In force
 · Medium confidence
In forceMedium confidence
US 12,559,748Compositions and Methods for the Treatment of Hemoglobinopathies
In force
 · High confidence
In forceHigh confidence
10 of 24 patents shown.
Pro members see all 24.
Pro members: see all 24 patents

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Published applications

US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.

35 pending · 27 abandoned · 1 no status recorded

List them

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited